Evaluate

Evaluate offers market intelligence, consensus forecasts, and analysis of the pharma, biotech, medical device, and diagnostic industries.

Evaluate offers market intelligence, consensus forecasts, and analysis of the pharma, biotech, medical device, and diagnostic industries. It supports critical business processes that require market trends and forecasts, competitive intelligence, performance evaluation, business strategy formulation and planning, partner/licensee/buyer identification and evaluation, development planning and optimization, product lifecycle management, risk management, logistics planning, market opportunity assessment and forecasts, product positioning, and regulatory and clinical benchmarking and planning. The company also provides market assessments and forecasts; plots future market opportunities; advices and makes investment decisions; identifies buyers and sellers; evaluates and closes deals; chooses and manages right investments; pitches new businesses; offers earnings and valuation estimates; and generates new investment opportunities for investment banks and other investment institutions. Evaluate serves pharmaceutical and biotechnology companies, financial institutions, and management consultancies; and service providers, including CROs, CMOs, and others. Evaluate was founded in 1996 and is headquatered in London, United Kingdom. It also has operations in Europe, the United States, Japan, and India. Evaluate operates as a subsidiary of Evaluate Group Ltd.